KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Other Non-Current Liabilities (2016 - 2026)

Supernus Pharmaceuticals has reported Other Non-Current Liabilities over the past 15 years, most recently at $22.2 million for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 192.0% to $22.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.2 million through Dec 2025, up 192.0% year-over-year, with the annual reading at $22.2 million for FY2025, 192.0% up from the prior year.
  • Other Non-Current Liabilities was $22.2 million for Q4 2025 at Supernus Pharmaceuticals, up from $7.8 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $69.0 million in Q3 2021 and troughed at $403000.0 in Q3 2024.
  • The 5-year median for Other Non-Current Liabilities is $9.8 million (2022), against an average of $23.6 million.
  • Year-over-year, Other Non-Current Liabilities crashed 98.17% in 2024 and then soared 1841.19% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $35.6 million in 2021, then crashed by 75.61% to $8.7 million in 2022, then decreased by 26.12% to $6.4 million in 2023, then grew by 18.34% to $7.6 million in 2024, then surged by 192.0% to $22.2 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Other Non-Current Liabilities are $22.2 million (Q4 2025), $7.8 million (Q3 2025), and $7.5 million (Q1 2025).